Pharma Journalist -

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of…
Read More...

SMi Reports: Bringing together industry experts to discuss the challenges and drivers of the industry This conference is a must-attend show for anyone involved in the parallel trade…
Read More...

The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults…
Read More...

MindMed a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with…
Read More...

PwC has announced the signing of an agreement with CPI, making it a partner in the Medicines Manufacturing Innovation Centre collaboration. The partnership will utilise PwC’s global…
Read More...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the Company is establishing a Center of…
Read More...

Molecular Templates, Inc. announced that it has entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies…
Read More...

Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater…
Read More...

AbbVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced that they have entered into a collaboration and license agreement…
Read More...

Following the European Medicines Agency (EMA) approval, millions of AstraZeneca vaccines began shipping on 5 February as part of the initial 17m doses that are due to be delivered over…
Read More...